Masayuki Kitano

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

Do‐Youn Oh, Aiwu Ruth He, Shukui Qin et al. · NEJM Evidence · 2022 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +14

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Do‐Youn Oh, Aiwu Ruth He, Mohamed Bouattour et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 254 citations · Full text

Medicine, Oncology, Pharmacology +11

Removal of diminutive colorectal polyps: A prospective randomized clinical trial between cold snare polypectomy and hot forceps biopsy

Yoriaki Komeda, Hiroshi Kashida, Toshiharu Sakurai et al. · World Journal of Gastroenterology · 2017 · 50 citations · Full text

Medicine, Oncology, Surgery +8

Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer.

Mohamed Bouattour, Juan W. Valle, Arndt Vogel et al. · Journal of Clinical Oncology · 2023 · 21 citations

Medicine, Oncology, Pharmacotherapy +15

Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial

Akihiro Ohba, Masato Ozaka, Junki Mizusawa et al. · Journal of Clinical Oncology · 2025 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15